217 related articles for article (PubMed ID: 8128091)
21. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
[TBL] [Abstract][Full Text] [Related]
22. [Needle biopsy of the pleura and medical alternatives in pleurisy of unknown etiology].
Slugin SP
Probl Tuberk; 1990; (3):48-51. PubMed ID: 2367508
[TBL] [Abstract][Full Text] [Related]
23. [Intrapleural administration of recombinant interleukin-2 in a patient with pleural effusion due to non-Hodgkin's lymphoma].
Kojiro N; Ishihara H; Ito M; Nishiki M; Yamashita K; Onoshi M
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):954-9. PubMed ID: 2615111
[TBL] [Abstract][Full Text] [Related]
24. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
Soiffer RJ; Murray C; Shapiro C; Collins H; Chartier S; Lazo S; Ritz J
Clin Cancer Res; 1996 Mar; 2(3):493-9. PubMed ID: 9816195
[TBL] [Abstract][Full Text] [Related]
25. [Colony-stimulating factor activity in malignant pleural effusions and its augmentation by local administration of interleukin 2].
Nakanishi M; Sone S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):824-8. PubMed ID: 1920977
[TBL] [Abstract][Full Text] [Related]
26. [Value of the assay of pleural carcinoembryonic antigen for the diagnosis of neoplastic pleurisy. Correlation with plasma levels and anatomopathological results].
Kasparian P; Saillard P; Guibout P
Sem Hop; 1983 Oct; 59(39):2678-82. PubMed ID: 6316520
[TBL] [Abstract][Full Text] [Related]
27. Malignant pleural effusions.
Sahn SA
Clin Chest Med; 1985 Mar; 6(1):113-25. PubMed ID: 2988851
[TBL] [Abstract][Full Text] [Related]
28. [Eosinophil colony stimulating activity induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy].
Nakamura Y; Ozaki T; Kamei T; Kawaji K; Fujisawa K; Nii A; Yanagawa H; Nishioka Y; Shimizu E; Sone S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1314-20. PubMed ID: 2273659
[TBL] [Abstract][Full Text] [Related]
29. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
[TBL] [Abstract][Full Text] [Related]
31. Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma: a Phase II study.
Astoul P; Picat-Joossen D; Viallat JR; Boutin C
Cancer; 1998 Nov; 83(10):2099-104. PubMed ID: 9827714
[TBL] [Abstract][Full Text] [Related]
32. Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma.
Chamberlain MH; Fareed K; Nakas A; Martin-Ucar AE; Waller DA
Eur J Cardiothorac Surg; 2008 Jul; 34(1):200-3. PubMed ID: 18450462
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage.
Bjermer L; Grönberg H; Roos G; Henriksson R
Biotherapy; 1993; 6(1):1-7. PubMed ID: 8507539
[TBL] [Abstract][Full Text] [Related]
35. Effects of interleukin-2 for the treatment of malignant mesothelioma.
Nano R; Capelli E; Civallero M; Terzuolo G; Volpini E; Nascimbene C; Cremaschi P
Oncol Rep; 1998; 5(2):489-92. PubMed ID: 9468586
[TBL] [Abstract][Full Text] [Related]
36. [Photomicrographs of a pleural biopsy specimen, showing malignant mesothelioma and necrosis--malignant pleural mesothelioma in a patient with sarcoidosis].
Matsuzawa K; Hamada K; Tokuyama T; Fu A; Nakaya M; Maeda K; Cho S; Narita N
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):687-91. PubMed ID: 9294306
[TBL] [Abstract][Full Text] [Related]
37. [Malignant mesothelioma: study of prognostic factors in a series of 188 cases].
Viallat JR; Boutin C; Rey F; Astoul P; Farisse P
Arch Anat Cytol Pathol; 1993; 41(5-6):205-11. PubMed ID: 8135581
[TBL] [Abstract][Full Text] [Related]
38. [Indications for intrapleural talc under pleuroscopic control in malignant recurrent pleural effusions. Based on 26 cases (author's transl)].
Migueres J; Jover A
Poumon Coeur; 1981; 37(5):295-7. PubMed ID: 7312762
[TBL] [Abstract][Full Text] [Related]
39. Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer.
Kammula US; White DE; Rosenberg SA
Cancer; 1998 Aug; 83(4):797-805. PubMed ID: 9708948
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
Macaulay VM; O'Byrne KJ; Saunders MP; Braybrooke JP; Long L; Gleeson F; Mason CS; Harris AL; Brown P; Talbot DC
Clin Cancer Res; 1999 Mar; 5(3):513-20. PubMed ID: 10100701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
